Terry Klein
Family Medicine · Wichita, KSNPI 1831151406
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,203 of the $6,657 with a category attached, or 63.1%. It is spread thinly across 34 manufacturers, the largest accounting for just 23.1%. Among family medicine clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 341 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
- Zealand Pharma A/s$1K
- AbbVie$875
- Novo Nordisk$582
- Amgen$546
- Seqirus USA Inc$421
- plus $1K from 28 others
Across 596 payments — averaging $9976.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$2.4M
- Vertex$657K
- Emergent Biosolutions Inc.$616K
- Sanofi Pasteur Inc.$419K
- Eisai Inc.$396K
- Modernatx, Inc.$266K
- plus $1.2M from 15 others
What the payments were for
- Travel & lodging$2,40236%
- Food & beverage$4,20363%
- Education$411%
- Gifts$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 19 | $1,540 |
| Zealand Pharma A/s | 2 | $1,239 |
| AbbVie(2 entities) | 95 | $875 |
| Novo Nordisk | 53 | $582 |
| Amgen | 42 | $546 |
| Seqirus USA Inc | 3 | $421 |
| Lilly USA, LLC | 22 | $209 |
| Eisai Inc. | 19 | $163 |
| Sanofi-aventis U.S. LLC | 11 | $149 |
| Amarin Pharma, Inc. | 8 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $100 |
| Pfizer | 7 | $80 |
| Abbott | 5 | $71 |
| Teva Pharmaceuticals USA, Inc. | 6 | $68 |
| Sunovion Pharmaceuticals Inc. | 10 | $57 |
| Otsuka America Pharmaceutical, Inc. | 4 | $48 |
| Boehringer Ingelheim | 3 | $38 |
| Esperion Therapeutics, Inc. | 3 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Novartis | 2 | $29 |
| GSK | 2 | $27 |
| Si-bone, Inc. | 1 | $27 |
| Ironwood Pharmaceuticals, Inc | 2 | $26 |
| Johnson & Johnson | 2 | $25 |
| AstraZeneca | 2 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Apria Healthcare LLC | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Medtronic | 1 | $14 |
| Edwards Lifesciences | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,657 in reported general payments places this provider in the 90th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Wichita
- Mila MeansWichita$241K
- Cole GillenwaterWichita$62K
- Hai TruongWichita$25K
- Deborah OutwaterWichita$25K
- Joseph SackWichita$21K
- Scott StringfieldWichita$20K
- Mark LeikerWichita$20K
- Paul DavisWichita$18K
- Tara NeilWichita$16K
- William SimonWichita$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.